Back to Search Start Over

Molecular genetic analysis of hyperhomocysteinemia.

Authors :
Hermus, A.R.M.M.
Heijer, M. den
Blom, H.J.
Gellekink, H.
Hermus, A.R.M.M.
Heijer, M. den
Blom, H.J.
Gellekink, H.
Source :
~~~~~~~~~~
Publication Year :
2007

Abstract

RU Radboud Universiteit Nijmegen, 11 januari 2007<br />Promotor : Hermus, A.R.M.M. Co-promotores : Heijer, M. den, Blom, H.J.<br />Item does not contain fulltext<br />Homocysteine is a intermediary product of protein metabolism. A high concentration of homocysteine in the blood is associated with a higher risk of cardiovascular disease, including venous thrombosis. Homocysteine levels are in part determined by genetic factors and vitamin intake (such as vitamin B12). The main goal of the presented research was to identify genetic factors (polymorphisms) that affect homocysteine levels and to assess if these polymorphisms also increased the risk of recurrent venous thrombosis. In addition, we evaluated vitamin B12 as a risk factor of recurrent venous thrombosis. We investigated a polymorphism in the catechol-O-methyltransferase gene, which is involved in so-called 'transmethylation reactions', in relation to homocysteine levels. Individuals carrying this polymorphism had higher homocysteine levels than subjects that did not carry this variant. In addition, this polymorphism was more common in recurrent venous thrombosis cases than the general population. This supports the hypothesis that high homocysteine reflects a disturbed transmethylation, which increases venous thrombosis risk. We also developed a method to study metabolites in the blood that report on the ability of our body to perform transmethylation reactions. It appeared that the way the blood samples were stabilized was of great importance for the reliability of our method. Future studies will have to point out whether a disturbed transmethylation is involved in the aetiology of venous thrombosis. Finally, we show that a low vitamin B12 status, which is a cause of high homocysteine levels, is associated with an increased risk of recurrent venous thrombosis. Measuring methylmalonic acid, a marker of intracellular vitamin B12 availability, seems more suitable for measuring vitamin B12 status than plasma vitamin B12 itself.

Details

Database :
OAIster
Journal :
~~~~~~~~~~
Publication Type :
Electronic Resource
Accession number :
edsoai.on1292464272
Document Type :
Electronic Resource